Potential new biomarkers for endometrial cancer.

Michelle H TownsendZac E EnceAbigail M FelstedAlyssa C ParkerStephen R PiccoloRichard A RobisonKim L O'Neill

Published in: Cancer cell international (2019)

Collectively, these data show that JAG2, AURKA, PGK1, and HRPT1 have the potential to be used independently as diagnostic, prognostic, or treatment biomarkers in endometrial cancer. Expression levels of these genes may provide physicians with insight into tumor aggressiveness and chemotherapy drugs that are well suited to individual patients.

Keyphrases

endometrial cancer
end stage renal disease
newly diagnosed
primary care
ejection fraction
chronic kidney disease
poor prognosis
genome wide
prognostic factors
human health
electronic health record
squamous cell carcinoma
binding protein
locally advanced
risk assessment
deep learning